Cerebral Blood Flow and Cognitive Performance in Postural Tachycardia Syndrome: Insights from Sustained Cognitive Stress Test
- PMID: 33280488
- PMCID: PMC7955388
- DOI: 10.1161/JAHA.120.017861
Cerebral Blood Flow and Cognitive Performance in Postural Tachycardia Syndrome: Insights from Sustained Cognitive Stress Test
Abstract
Background The physiology underlying "brain fog" in the absence of orthostatic stress in postural tachycardia syndrome (POTS) remains poorly understood. Methods and Results We evaluated cognitive and hemodynamic responses (cardiovascular and cerebral: heart rate, blood pressure, end-tidal carbon dioxide, and cerebral blood flow velocity (CBFv) in the middle cerebral artery at baseline, after initial cognitive testing, and after (30-minutes duration) prolonged cognitive stress test (PCST) whilst seated; as well as after 5-minute standing in consecutively enrolled participants with POTS (n=22) and healthy controls (n=18). Symptom severity was quantified with orthostatic hypotensive questionnaire at baseline and end of study. Subjects in POTS and control groups were frequency age- and sex-matched (29±11 versus 28±13 years; 86 versus 72% women, respectively; both P≥0.4). The CBFv decreased in both groups (condition, P=0.04) following PCST, but a greater reduction in CBFv was observed in the POTS versus control group (-7.8% versus -1.8%; interaction, P=0.038). Notably, the reduced CBFv following PCST in the POTS group was similar to that seen during orthostatic stress (60.0±14.9 versus 60.4±14.8 cm/s). Further, PCST resulted in greater slowing in psychomotor speed (6.1% versus 1.4%, interaction, P=0.027) and a greater increase in symptom scores at study completion (interaction, P<0.001) in the patients with POTS, including increased difficulty with concentration. All other physiologic responses (blood pressure and end-tidal carbon dioxide) did not differ between groups after PCST (all P>0.05). Conclusions Reduced CBFv and cognitive dysfunction were evident in patients with POTS following prolonged cognitive stress even in the absence of orthostatic stress.
Keywords: cerebral blood flow; cognitive dysfunction; orthostatic intolerance; postural tachycardia syndrome; transcranial doppler.
Conflict of interest statement
Dr Linz reports having served on the advisory board of LivaNova and Medtronic. Dr Linz reports the UoA has received on his behalf lecture and/or consulting fees from LivaNova, Medtronic, and ResMed. Dr Linz reports the UoA has received on his behalf research funding from Sanofi, ResMed, and Medtronic. Dr Sanders reports having served on the advisory board of Medtronic, Abbott Medical, Boston Scientific, Pacemate, and CathRx. Dr Sanders reports that the UoA has received on his behalf lecture and/or consulting fees from Medtronic, Abbott Medical, Bayer, and Boston Scientific. Dr Sanders reports that the UoA has received on his behalf research funding from Medtronic, Abbott Medical, Boston Scientific, and MicroPort. Dr Lau reports that the UoA has received on his behalf lecture and/or consulting fees from Abbott Medical, Bayer, Biotronik, Boehringer Ingelheim, Medtronic, MicroPort, and Pfizer.
Figures



References
-
- Bryarly M, Phillips LT, Fu Q, Vernino S, Levine BD. Postural orthostatic tachycardia syndrome: Jacc focus seminar. J Am Coll Cardiol. 2019;73:1207–1228. - PubMed
-
- Fu Q, Arbab‐Zadeh A, Perhonen MA, Zhang R, Zuckerman JH, Levine BD. Hemodynamics of orthostatic intolerance: Implications for gender differences. Am J Physiol Heart Circ Physiol. 2004;286:H449–457. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources